• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重复接种灭活或减毒活流感疫苗后反应频率降低。

Reduced reaction frequencies with repeated inactivated or live-attenuated influenza vaccination.

作者信息

Ohmit Suzanne E, Gross Jonathan, Victor John C, Monto Arnold S

机构信息

University of Michigan School of Public Health, Ann Arbor, MI 48109, USA.

出版信息

Vaccine. 2009 Feb 11;27(7):1050-4. doi: 10.1016/j.vaccine.2008.11.100. Epub 2008 Dec 16.

DOI:10.1016/j.vaccine.2008.11.100
PMID:19095028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2665993/
Abstract

Data collected as part of a multi-year trial examining the efficacies of inactivated and live-attenuated influenza vaccines were used to evaluate the reported occurrence of post-vaccination reactions. Two cohorts were defined: (1) individuals who received the same vaccine over two consecutive years, and (2) individuals who first enrolled in year 2 of the study and received vaccine only in that year. For both vaccines there were significantly fewer reactions reported in year 2 in those subjects who were vaccinated both years. Declines were demonstrated when comparing year 1 and 2 reaction frequencies in subjects vaccinated both years, and differences were seen when comparing year 2 reaction frequencies in subjects vaccinated both years with those first vaccinated in year 2. Reaction reporting peaked on post-vaccination days 0 and 1 following receipt of the inactivated vaccine, and on day 2 following receipt of the live-attenuated vaccine.

摘要

作为一项多年期试验的一部分收集的数据,该试验旨在检验灭活流感疫苗和减毒活流感疫苗的效力,用于评估报告的接种后反应发生率。定义了两个队列:(1)连续两年接种相同疫苗的个体,以及(2)在研究的第2年首次入组且仅在该年接种疫苗的个体。对于两种疫苗,在两年都接种疫苗的受试者中,第2年报告的反应明显较少。在比较两年都接种疫苗的受试者第1年和第2年的反应频率时显示出下降,并且在比较两年都接种疫苗的受试者与第2年首次接种疫苗的受试者的第2年反应频率时发现了差异。接种灭活疫苗后,反应报告在接种后第0天和第1天达到峰值,接种减毒活疫苗后在第2天达到峰值。

相似文献

1
Reduced reaction frequencies with repeated inactivated or live-attenuated influenza vaccination.重复接种灭活或减毒活流感疫苗后反应频率降低。
Vaccine. 2009 Feb 11;27(7):1050-4. doi: 10.1016/j.vaccine.2008.11.100. Epub 2008 Dec 16.
2
Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial.一种减毒活流感H5候选疫苗株A/17/火鸡/土耳其/05/133 H5N2的安全性和免疫原性及其对潜在大流行前使用的启动作用:一项随机、双盲、安慰剂对照试验。
Lancet Infect Dis. 2017 Aug;17(8):833-842. doi: 10.1016/S1473-3099(17)30240-2. Epub 2017 May 19.
3
Comparative efficacy of inactivated and live attenuated influenza vaccines.灭活流感疫苗与减毒活流感疫苗的比较疗效
N Engl J Med. 2009 Sep 24;361(13):1260-7. doi: 10.1056/NEJMoa0808652.
4
Assessing Fever Frequency After Pediatric Live Attenuated Versus Inactivated Influenza Vaccination.评估儿童接种减毒活疫苗与灭活流感疫苗后的发热频率。
J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e7-e14. doi: 10.1093/jpids/piw028.
5
Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older.比较 65 岁及以上人群接种含佐剂和高剂量流感疫苗的上市后安全性特征。
JAMA Netw Open. 2020 May 1;3(5):e204079. doi: 10.1001/jamanetworkopen.2020.4079.
6
Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children.一项随机试验,旨在比较CSL有限公司2009年三价灭活流感疫苗与美国一种已获认可的疫苗对美国儿童的安全性和免疫原性。
Vaccine. 2014 Dec 12;32(52):7141-7. doi: 10.1016/j.vaccine.2014.10.024. Epub 2014 Oct 29.
7
Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults.四价流感病毒灭活疫苗在成年人中的安全性和免疫原性。
Vaccine. 2013 Nov 12;31(47):5572-8. doi: 10.1016/j.vaccine.2013.08.069. Epub 2013 Sep 7.
8
Influenza vaccine for chronic obstructive pulmonary disease (COPD).用于慢性阻塞性肺疾病(COPD)的流感疫苗。
Cochrane Database Syst Rev. 2018 Jun 26;6(6):CD002733. doi: 10.1002/14651858.CD002733.pub3.
9
Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study.大流行前A/H5N2流感减毒活候选疫苗在成年志愿者中的临床试验:一项安慰剂对照、随机双盲I期研究的结果
Vaccine. 2015 Sep 22;33(39):5110-7. doi: 10.1016/j.vaccine.2015.08.019. Epub 2015 Aug 19.
10
Safety of Russian-Backbone Trivalent, Live Attenuated Seasonal Influenza Vaccine in Healthy Subjects: Open-Label, Non-randomized Phase 4 Study.俄罗斯三价、活减毒季节性流感疫苗在健康受试者中的安全性:开放标签、非随机 4 期研究。
Drug Saf. 2018 Feb;41(2):171-177. doi: 10.1007/s40264-017-0605-3.

引用本文的文献

1
Evaluation of multivalent H2 influenza pandemic vaccines in mice.小鼠多价H2流感大流行疫苗的评估。
Vaccine. 2017 Mar 7;35(10):1455-1463. doi: 10.1016/j.vaccine.2017.01.026. Epub 2017 Feb 8.
2
The immune response to 6-monthly versus annual standard dose inactivated trivalent influenza vaccination in older people: study protocol for a randomised clinical trial.老年人每6个月与每年接种标准剂量三价灭活流感疫苗的免疫反应:一项随机临床试验的研究方案
Trials. 2017 Feb 10;18(1):67. doi: 10.1186/s13063-017-1808-8.
3
Options and obstacles for designing a universal influenza vaccine.

本文引用的文献

1
Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines.2005 - 2006年期间灭活疫苗和减毒活疫苗对有症状季节性流感的预防作用
J Infect Dis. 2008 Aug 1;198(3):312-7. doi: 10.1086/589885.
2
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007.流感的预防与控制。免疫实践咨询委员会(ACIP)2007年建议
MMWR Recomm Rep. 2007 Jul 13;56(RR-6):1-54.
3
Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines.
设计通用流感疫苗的选择与障碍
Viruses. 2014 Aug 18;6(8):3159-80. doi: 10.3390/v6083159.
4
Safety of a Trivalent Inactivated Influenza Vaccine in Health Care Workers in Kurdistan Province, Western Iran; A Longitudinal Follow-up Study.伊朗西部库尔德斯坦省医护人员中三价灭活流感疫苗的安全性:一项纵向随访研究
Iran J Med Sci. 2014 Mar;39(2 Suppl):218-22.
5
Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial.鼠李糖乳杆菌 GG 作为免疫佐剂增强健康成年人用减毒流感活疫苗的效果:一项随机、双盲、安慰剂对照试验。
Eur J Clin Nutr. 2011 Apr;65(4):501-7. doi: 10.1038/ejcn.2010.289. Epub 2011 Feb 2.
通过灭活疫苗和减毒活疫苗预防抗原性漂移流感。
N Engl J Med. 2006 Dec 14;355(24):2513-22. doi: 10.1056/NEJMoa061850.
4
Universal influenza vaccination in the United States: are we ready? Report of a meeting.美国的通用流感疫苗接种:我们准备好了吗?会议报告
J Infect Dis. 2006 Nov 1;194 Suppl 2:S147-54. doi: 10.1086/507556.
5
Guillain-Barré syndrome after influenza vaccination in adults: a population-based study.成人流感疫苗接种后发生吉兰-巴雷综合征:一项基于人群的研究。
Arch Intern Med. 2006 Nov 13;166(20):2217-21. doi: 10.1001/archinte.166.20.2217.
6
Safety of influenza vaccinations administered in nontraditional settings.在非传统环境中接种流感疫苗的安全性。
Vaccine. 2006 May 1;24(18):4024-7. doi: 10.1016/j.vaccine.2005.09.061. Epub 2006 Feb 9.
7
Adverse events reported following live, cold-adapted, intranasal influenza vaccine.接种减毒活流感病毒鼻内疫苗后报告的不良事件。
JAMA. 2005 Dec 7;294(21):2720-5. doi: 10.1001/jama.294.21.2720.
8
Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.2岁以下儿童接种灭活流感疫苗后的不良事件:1990 - 2003年疫苗不良事件报告系统报告分析
Pediatrics. 2005 Feb;115(2):453-60. doi: 10.1542/peds.2004-1519.
9
Determinants of influenza vaccination, 2003-2004: shortages, fallacies and disparities.2003 - 2004年流感疫苗接种的决定因素:短缺、谬误与差异
Clin Infect Dis. 2004 Dec 15;39(12):1824-8. doi: 10.1086/427153. Epub 2004 Nov 18.
10
Influenza vaccination and self-reported reasons for not receiving influenza vaccination among Medicare beneficiaries aged > or =65 years--United States, 1991-2002.1991 - 2002年美国65岁及以上医疗保险受益人的流感疫苗接种情况及自我报告的未接种流感疫苗原因
MMWR Morb Mortal Wkly Rep. 2004 Nov 5;53(43):1012-5.